Inventor · disambiguated record
Charles Nicolette
Also filed as: NICOLETTE CHARLES · NICOLETTE CHARLES A
12 granted patents·37 pending applications·133 citations·filing 1997–2022
90Inventor score
Top patents by PatentIndex Score
49 records- 0183US6528060B1Therapeutic compoundsGENZYME CORP·Filed 2000·Granted Mar 4, 2003·17 cites·2 claims
- 0282US6579970B2Therapeutic anti-cytomegalovirus compoundsGENZYME CORP·Filed 2001·Granted Jun 17, 2003·15 cites·7 claims
- 0382US6306640B1Melanoma antigenic peptidesGENZYME CORP·Filed 1999·Granted Oct 23, 2001·52 cites·10 claims
- 0478US7202331B2Therapeutic anti-cytomegalovirus compoundsGENZYME CORP·Filed 2003·Granted Apr 10, 2007·9 cites·1 claims
- 0576US6737062B2Immunogenic compositionsGENZYME CORP·Filed 2001·Granted May 18, 2004·9 cites·3 claims
- 0674US8513208B2Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejectionNICOLETTE CHARLES A·Filed 2009·Granted Aug 20, 2013·2 cites·9 claims
- 0774US2023158109A1Use of cd83 in combination therapiesCOLMMUNE INC·Filed 2022·Application pending·0 cites
- 0868US2014010821A1Use of CD83 in combination therapiesLAO AILI·Filed 2007·Application pending·0 cites
- 0966US6338945B1Method for identifying cytotoxic T-cell epitopesGENZYME CORP·Filed 1997·Granted Jan 15, 2002·27 cites·23 claims
- 1065US6861408B2Therapeutic anti-melanoma compoundsGENZYME CORP·Filed 2001·Granted Mar 1, 2005·2 cites·6 claims
- 1161US8029796B2Therapeutic anti-cytomegalovirus compoundsGENZYME CORP·Filed 2007·Granted Oct 4, 2011·0 cites·2 claims
- 1259US2016324926A1Use of CD83 in Combination TherapiesARGOS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1359US2016008440A1Use of CD83 in Combination TherapiesARGOS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1455US2005069960A1Novel complementing receptor-ligand pairs and adoptive immunotherapy using the sameFiled 2004·Application pending·0 cites
- 1553US2002172979A1Method for identifying cytotoxic T-cell epitopesFiled 2002·Application pending·0 cites
- 1652US2004014697A1Melanoma antigenic peptidesFiled 2001·Application pending·0 cites
- 1751US2006159662A1Therapeutic anti-melanoma compoundsNICOLETTE CHARLES A·Filed 2005·Application pending·0 cites
- 1851US2005202458A1Antigen-specific cells, methods of generating these cells and uses thereofFiled 2004·Application pending·0 cites
- 1951US2005059056A1Antigenic gp100 (154-162) compounds for therapy and diagnosis and methods for using sameFiled 2004·Application pending·0 cites
- 2050US2005048068A1Therapeutic compounds for ovarian cancerFiled 2004·Application pending·0 cites
- 2149US2005281834A1Altered peptide ligandsGENZYME CORP·Filed 2005·Application pending·0 cites
- 2248US2003162720A1Therapeutic anti-HIV (IV9) compoundsFiled 2002·Application pending·0 cites
- 2348US2003147866A1Novel BGP compounds for therapy and diagnosis and methods for using sameFiled 2002·Application pending·0 cites
- 2448US2005196860A1Novel EPS8 compounds for therapy and diagnosis and methods for using sameFiled 2002·Application pending·0 cites
- 2547US11779599B2Methods and uses for dendritic cell therapyCOIMMUNE INC·Filed 2018·Granted Oct 10, 2023·0 cites·20 claims
- 2647US2002197243A1Novel p53BP2 compounds for therapy and diagnosis and methods for using sameFiled 2002·Application pending·0 cites
- 2747US2003165517A1Therapeutic anti-HIV (vpr) compoundsFiled 2002·Application pending·0 cites
- 2847US2003147905A1Therapeutic compoundsFiled 2003·Application pending·0 cites
- 2946US2002187494A1PAR-3 compounds for therapy and diagnosis and methods for using sameFiled 2002·Application pending·0 cites
- 3046US2006099202A1Immunoglobulin construct containing tumor- specific p53bp2 sequenes for eliciting an anti-tumor responseEURO CELTIQUE SA·Filed 2002·Application pending·0 cites
- 3145US2003013075A1MART-1 compounds for therapy and diagnosis and methods for using sameFiled 2002·Application pending·0 cites
- 3245US2002164346A1Altered peptide ligandsFiled 2002·Application pending·0 cites
- 3345US2002169132A1Therapeutic anti-melanoma compoundsFiled 2001·Application pending·0 cites
- 3445US2002122791A1Antigenic CK-18 compounds for therapy and diagnosis and methods for using sameFiled 2001·Application pending·0 cites
- 3545US2002155471A1Compounds for therapy and diagnosis and methods for using sameFiled 2001·Application pending·0 cites
- 3644US9085807B2Strain-independent amplification of pathogens and vaccines theretoNICOLETTE CHARLES·Filed 2005·Granted Jul 21, 2015·0 cites·17 claims
- 3744US2002182218A1Therapeutic anti-melanoma compoundsFiled 2001·Application pending·0 cites
- 3844US2002160959A1Therapeutic compounds for ovarian cancerFiled 2001·Application pending·0 cites
- 3944US2006014668A1Antigenic gp 100 compounds for therapy and diagnosis and methods of using sameNICOLETTE CHARLES A·Filed 2005·Application pending·0 cites
- 4043US2002018766A1Genes differentially expressed in cancer cells to design cancer vaccinesFiled 2001·Application pending·0 cites
- 4143US2002006412A1Preparation and use of particulates composed of adenovirus particlesFiled 2001·Application pending·0 cites
- 4243US2004138135A1Therapeutic compounds for ovarian cancerFiled 2001·Application pending·0 cites
- 4342US9879053B2Strain-independent amplification of pathogens and vaccines theretoARGOS THERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·0 cites·11 claims
- 4442US2023061319A1Methods of treating tumorsCOIMMUNE INC·Filed 2021·Application pending·0 cites
- 4540US2002041868A1Cell fusions and methods of making and using the sameFiled 2001·Application pending·0 cites
- 4640US2002094530A1Method to identify antibody targetsFiled 2001·Application pending·0 cites
- 4738US2021317410A1Methods of making natural killer cells and uses thereofCOIMMUNE INC·Filed 2019·Application pending·0 cites
- 4832US2019315878A1Bispecific antibodies that modulate tlr-4 signaling and uses thereofARGOS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4929US2017065690A1Tscm CELLS AND METHODS FOR USEARGOS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Nicolette files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →